News

Still being built, but visit the Fluidda booth at the ERS congress, starting tomorrow in Madrid, to experience state of
Read More
This study will be presented at ERS 2019 at a thematic poster session on Tuesday October 1st between 12.50 pm
Read More
This study will be presented at ERS 2019 at a thematic poster session on Monday September 30 between 12.50 pm
Read More
This study will be presented at ERS 2019 at a thematic poster session on Sunday September 29 between 12.50 pm
Read More
From  September 28 until October 2, Fluidda will exhibit at the annual conference of the European Respiratory Society in Madrid, Spain.
Read More
FLUIDDA is the leading company in the field of Functional Respiratory imaging (FRI). FLUIDDA develops respiratory solutions to detect lung
Read More
In a recently published study (click here for full article)10 patients with unstable, severe asthma were treated with bronchial thermoplasty
Read More
During July 8-10 the International Conference of Medical imaging with Deep Learning takes place in London. The FLUIDDA team, specialised
Read More
This year's symposium will take place in Paris on July 1-2. Each year the meeting brings leading scientists in the
Read More
De Backer states: “We are very excited and proud to enter into this new phase of partnership with Materialise. We
Read More
At the yearly conference of the European Cystic Fibrosis Society which takes place from June 5-8 in liverpool (UK), the
Read More
FIGHT is a non-profit charity project which has been established together with FLUIDDA, focusing on research of the lung health
Read More
At the recent ATS 2019 conference in Dallas, Texas, two posters were presented on research using Fluidda's Functional Respiratory Imaging
Read More
At IRDD, May 30 in New York, Dr. De Backer will discuss the clinical relevance of understanding regional lung structure
Read More
Jan de Backer, CEO and founder of FLUIDDA, has been appointed to the Board of Directors of the new global
Read More
Esther Daemen, FLUIDDA's Quality and Training Officer and certified Data Protection Officer (DPO), will be representing us at the ‘Outsourcing
Read More
Study results will be presented at the upcoming ATS conference in Dallas on Sunday, May 19, 2:15-4:15 PM, Trinity Ballroom
Read More
Next week, Fluidda will exhibit at the annual American Thoracic Society International Conference ATS 2019 in Dallas, Texas. The ATS,
Read More
From May 7-10 the Annual Respiratory Drug Delivery Congress (RDD) will take place in Estoril, Portugal. During this conference, Fluidda
Read More
The press release of the collaboration between FLUIDDA and Materialise was published on DeTijd: https://www.tijd.be/nieuws/archief/materialise-investeert-in-luchtwegscanner/10121071
Read More
Materialise invests 2.5mio EUR in Fluidda as part of a 4mio EUR Funding round. Fluidda announces a new phase in
Read More
Next month  Fluidda will exhibit at the annual American Thoracic Society International Conference ATS 2019 in Dallas, Texas. The ATS,
Read More
Last October, Wouter van Geffen, pulmonologist at the Medical Center Leeuwarden, The Netherlands, was awarded his PhD degree for this
Read More
Jan de Backer, MSc,PhD,MBA. CEO of FLUIDDA recently became member of the advisory board of the RIS. The Respiratory Innovation
Read More
From May 7-10 the Respiratory Drug Delivery congress (RDD) will take place in Estoril, Portugal. This annual congress is focussed
Read More
On Friday May 17, just before the start of the annual congress of the American Thoracic Society (ATS) in Dallas,
Read More
In this case study we used the quantitative CT approach called Functional Respiratory Imaging (FRI) to assess the effect of
Read More
FLUIDDA’s technology mentioned by Forbes as revolutionizing Respiratory Care: www.forbes.com
Read More
For the next 5 days the FLUIDDA team will be present at the annual European Respiratory Society conference in Paris.
Read More
We are happy to announce that a few days ago the positive results of AstraZeneca’s Bevespi (LABA/LAMA), compared to placebo
Read More
A thorough understanding of a pharmaceutical company’s target disease is imperative when it wants to successfully develop and market its
Read More
We’ve said it before: the respiratory field is the most expensive one in the pharmaceutical world. The low sensitivity of
Read More
Cystic fibrosis (CF) is a devastating, chronic disease that affects over 100,000 people worldwide. The consequences patients need to bear
Read More
In the previous blogpost the complexity of delivering inhaled drugs into the lung was discussed. It was shown that functional
Read More
Not only will FLUIDDA present at the first Respiratory Innovation Summit at the American Thoracic Society conference 2018, we also have a
Read More
Drug inhalation. It is one of the most important aspects in the day-to-day life of patients with respiratory disease. But
Read More
Excited to announce that FLUIDDA was selected as one of the companies to present at the first Respiratory Innovation Summit at
Read More
Our Functional Respiratory Imaging technology including AI is well on its way to significantly help lung transplant patients. Excellent collaboration
Read More
The US Food and Drug administration has issued a letter of support to FLUIDDA after examination of study results where
Read More
Los Angeles, January 5th 2018 FLUIDDA Inc and the University of California, San Francisco (UCSF) are entering into a new
Read More
The opening of an office in Los Angeles (West Hollywood), California, marks the further expansion of FLUIDDA's global presence. With
Read More
With the end of the year approaching it is always good to take a moment and reflect on the year
Read More
Functional Respiratory Imaging (FRI) was featured on the cover of the November/December issue of WIREs Systems Biology and Medicine. Click
Read More
Our COO Wim Vos had a very interesting discussion this morning on drug delivery into the lungs of children and
Read More
Management Forum is currently having its 2-day annual conference inhaled drug development. Industry leaders are coming together on November 13
Read More
Many thanks to all of you who attended our Investors and Analysts Event in New York City. For those who
Read More
FLUIDDA is excited to join the IPF Catalyst Challenge! Functional Respiratory Imaging (FRI) is a very promising tool for early
Read More
We are looking for a Machine Intelligence engineer. Are you interested in researching on disease phenotype classification and therapy recommendation
Read More
For those who cannot attend our event coming Thursday at Flanders House in New York, you are welcome to register
Read More
As the European Respiratory Society Conference has finished, we would like to share the presentation slides and posters FLUIDDA has
Read More
At the recent European Respiratory Society conference in Milan a collaboration between CIRO and FLUIDDA materialized in an effort to
Read More
Visit us at booth G09 at ERS to experience lung physiology in Virtual Reality!!
Read More
"Functional Respiratory Imaging (FRI) provided valuable insights throughout the development process of iNO in COPD patients with PH. The therapy
Read More
"Wat heeft een ruimtevaartingenieur te maken met onze longen? Veel, zo blijkt in het geval van Jan De Backer, CEO van FLUIDDA.
Read More
By Dr. Jan De Backer, CEO FLUIDDA In the wake of a very successful IPF summit in Boston, and with
Read More
Posted first on Pulse May 8 2015 By Dr. Jan De Backer, CEO FLUIDDA "The same principles that keep us
Read More
At this year's ERS, the FLUIDDA team will demonstrate how Functional Respiratory Imaging can be of value in clinical practice
Read More
As the European Respiratory Society Conference is approaching rapidly, FLUIDDA is proud to announce that a total of 9 abstracts
Read More
Exciting new results will be presented at the upcoming European Respiratory Society Conference in Milan from 9-13 September! The primary
Read More
" We were very impressed by the additional insights FRI brought to this clinical trial. The FRI data gave us confidence
Read More
"The U.S. Food and Drug Administration approved the design of a Phase 2b trial of INOpulse, a device that delivers
Read More
Chronic rejection or Bronchiolitis Obliterans Syndrome (BOS) remains the most important cause of death in lung transplant patients. Diagnosing BOS
Read More
In line with FDA commissioner's, Dr Gottlieb, latest blog, FLUIDDA launched a comprehensive FDA Biomarker Approval initiative focusing on Idiopathic Pulmonary
Read More
FLUIDDA’s CEO Dr. Jan De Backer will present at IPF Summit in Boston next month. Dr De Backer will discuss
Read More
(This post first appeared on Pulse) Machine Learning and Artificial Intelligence in Healthcare require reliable data with low variability, accurately
Read More
Get your copy today using the ATS discount code via: https://www.broncholab.com/#/book or stop by our booth #1048 at ATS, Washington
Read More
Order now at: www.broncholab.com Excellent reference to increase your understanding of Lung Diseases and how they affect Lung Health. Whether
Read More
Check out our new video of a lung tumor render:
Read More
In this video you can see the FRI-based aerosol deposition.
Read More
We are ready to show the more than 20,000 respiratory healthcare professionals at ERS 2016 our new Broncholab platform! Broncholab
Read More
FLUIDDA is proud to announce the launch of her Broncholab platform, now providing the award-winning Functional Respiratory Imaging technology to
Read More
(This post first appeared on Pulse) As a patient I would like my doctor to be able to not only tap
Read More
The US Food and Drug Administration has issued a letter of support for FLUIDDA’s Functional Respiratory Imaging (FRI) technology. The
Read More
FLUIDDA’s mission: improving the health of respiratory patients ATS 2016 contribution: 7 abstracts in the scientific program. Tuesday, May 17,
Read More
11.03.2016 De KBC Toren in Antwerpen was op donderdag 10 maart het decor van een strijd der titanen. Derek Dendievel
Read More
FLUIDDA will be featured on Kanaal Z this Saturday 5th March 2016.
Read More
(This post first appeared on acquisition-intl.com) ‘Acquisition International magazine’ informeert wereldwijd meer dan 53.000 beslissers met intelligente overzichten en financiële
Read More
The FLUIDDA team proudly presents 12 abstracts at ERS (European Respiratory Society) International Congress.  26 - 30 September 2014 at the
Read More
This post first appeared on Pulse It is time we make the patient an integral part of the new treatment paradigms.
Read More
The FLUIDDA team proudly presents 12 abstracts at ATS (American Thoracic Society) International Congress from 15-20 May 2015 in Denver,
Read More
Understanding the interaction between Inhaled and Systemic Drugs using FRI: the Roflumilast Case
Read More
Disease progression in IPF assessed using pulmonary function tests and Functional Respiratory Imaging (FRI) - A pilot study
Read More
The FLUIDDA team proudly presents 18 abstracts at ERS (European Respiratory Society) International Congress.  6 - 10 September 2014 at
Read More